The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Prevalence of hepatitis C (HCV) among people who inject drugs in Europe is very high – in excess of 50% across six countries in the region and an estimated 84% in Portugal. But a new report released by EU drug body for World Hepatitis Day (July 28), shows that a combination of new treatments and prevention interventions gives significant reason for optimism in curbing the HCV epidemic among drug users in the region.
Pilot study demonstrates that delivering antiretroviral treatment to individuals presenting to emergency departments with suspected acute HIV infection is highly feasible,